News

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., ...
Bravecto Quantum is the first FDA-approved drug that treats and prevents flea and tick infestations on dogs for a duration of ...
A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...
Rahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., ...
Merck's animal health division received Food and Drug Administration approval for its once-yearly injectable flea-and-tick treatment for dogs. Merck Animal Health said Thursday it expects its Bravecto ...
The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older ...
The Food and Drug Administration has approved a first of its kind, once-yearly shot designed to protect dogs from fleas and ...
Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in ...
Global Animal Health Market is expected to grow at a rate of 8-9% by 2029. Growing awareness of animal health products, ...
SAN DIEGO, CA, UNITED STATES, July 2, 2025 /EINPresswire.com/ -- Stellar Market Research examines the growth rate of the Veterinary Pain Management Market during the forecasted period 2025-2032 The ...
Merck is set to announce its second-quarter results later this month, and analysts anticipate double-digit earnings dip.